BioCapital
Filter News
Found 36,553 articles
-
BioSpace Hotbed maps have been a life sciences industry staple for over 30 years. Today the program features eight regional Hotbed Maps and the NextGen Bio Map which highlights some of the industry’s most promising startups.
-
Governments across the globe have flexed their financial muscles to secure promises of as many doses of COVID-19 vaccines as possible when they become available.
-
BioSpace Movers & Shakers. Dec. 4
12/4/2020
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China
12/4/2020
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced the advancement of clinical development of the highly differentiated anti-CD47 monoclonal antibody lemzoparlimab (also known as TJC4) in the US and China, achieving milestones as planned.
-
Adial Pharmaceuticals Lead Drug Candidate AD04 for Treatment of Alcohol Use Disorder Featured in Follow-up TV News Story
12/4/2020
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, reports that its lead drug candidate, AD04, a therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in persons with certain target genotypes related to the serotonin transporter and receptor genes, has been featured on local TV
-
Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting
12/4/2020
Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that three abstracts relating to its immuno-oncology drug development have been accepted for presentation at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition to be held as a virtual event on December 5-8, 2020
-
Clinical Trials Offer Opportunities to Change Practice to Improve Prevention and Treatment of Blood Disorders
12/4/2020
Four studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition present opportunities to improve care for patients with a variety of blood disorders. Together, the studies provide supp
-
As if attempting to steal hard-won research wasn’t bad enough, hackers are now hitting people where it really hurts – with e-documents containing malicious code embedded in false offers of employment.
-
Ascentage Pharma Appoints Mr. Gang Zhu as Chief Commercial Officer to Lead Commercial Initiatives
12/3/2020
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the appointment of Mr. Gang Zhu
-
ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy
12/3/2020
RLS-0071 positioned as a novel pharmacological intervention to improve survival and cognitive outcomes for newborns affected by devastating disease
-
The USO Receives $3 Million Lilly Endowment Inc. Grant to Support Combat COVID-19 Initiative
12/3/2020
Generous grant enables USO's expansion of programs providing pandemic relief and recovery and ensures resilience of military communities in Indiana, the U.S. and the world
-
ATCC Introduces New Product Segment with Launch of SARS-CoV-2 External Control Kit
12/3/2020
ATCC, the world's premier biological materials management and standards organization, today announced the introduction of its new SARS-CoV-2 External Control Kit for clinical laboratories and test manufacturers.
-
Luna Innovations Acquires OptaSense
12/3/2020
Combination transforms Luna into a global fiber optic leader; creates a distributed fiber sensing powerhouse Acquisition combines two global leaders in fiber optic sensing solutions OptaSense’s market-leading position in distributed acoustic sensing (DAS) combined with Luna’s suite of sensing products forms the industry’s most comprehensive portfolio
-
Sirnaomics to Initiate Phase I Study of STP705 in Treatment of Primary and Metastatic Liver Cancer
12/3/2020
Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, announced today that the company has received feedback from the U.S. Food and Drug Administration (FDA) and may now proceed with a planned Phase I clinical s
-
58th Annual AUA Award Winners Announced
12/3/2020
2021 Awards Recognize Top Urologists, Honor Service to Specialty and Society
-
Truist Foundation supports American Red Cross humanitarian mission through Annual Disaster Giving Program
12/3/2020
the American Red Cross is recognizing Truist Foundation, headquartered in Charlotte, North Carolina, for supporting Red Cross Disaster Relief through the Annual Disaster Giving Program with an annual grant of $1 million.
-
Caretaker Medical Announces Health Canada Clearance Under the COVID-19 Interim Authorization
12/3/2020
Immediate Availability of Caretaker Wireless Patient Monitor for Touchless, Clinically Distanced, Continuous Blood Pressure and ICU Quality Vital Signs
-
NRMP Medical Specialties Matching Program (MSMP) Appoints 5,208 Residents to Advanced Training Positions
12/3/2020
The National Resident Matching Program® has released the results of the 2020 Medical Specialties Matching Program.
-
AstraZeneca Demonstrates Growing Leadership in Breast Cancer at SABCS with Data From Its Innovative Medicines and Robust Pipeline
12/3/2020
New data from the DESTINY-Breast01 trial reinforce the efficacy of ENHERTU ® in HER2-positive metastatic breast cancer New data from the SERENA-1 Phase I trial show strong efficacy and safety profile for next-generation oral SERD AZD9833 in HR-positive advanced breast cancer
-
On Tuesday, the CDC Advisory Committee on Immunization Practices voted 13-1 in support of this recommendation.